EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study

I J Beijert, Y van den Burgt, A E Hentschel, J Bosschieter, P C Kauer, B I Lissenberg-Witte, R J A van Moorselaar, J A Nieuwenhuijzen, R D M Steenbergen

World Journal of Urology · 16.10.2024 · 42 (1)

DOI: 10.1007/s00345-024-05287-5 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift World Journal of Urology, online erschienen am 16.10.2024. Verfasst von I J Beijert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, DNA Methylation, Biomarkers, Tumor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although cystoscopy is a reliable tool for detecting bladder cancer, it poses a high burden on patients and entails high costs. This highlights the need for non-invasive and cost-effective alternatives. This study aimed to validate a previously developed urinary methylation marker panel containing GHSR and MAL .

Methods

We enrolled 134 patients who underwent cystoscopy because of hematuria, including 63 individuals with primary bladder cancer and 71 with non-malignant findings. Urine samples were self-collected at home and sent via regular mail. Subsequently, DNA was extracted and the hypermethylation of GHSR and MAL was evaluated using quantitative methylation-specific polymerase chain reaction. The performance of methylation markers was assessed using area-under-the-curve (AUC) analysis and sensitivity and specificity based on pre-established cut-off values.

Results

Validation of the marker panel GHSR/MAL resulted in an AUC of 0.87 at 79% sensitivity and 80% specificity. Sensitivity was comparable to the previous investigation ( P > 0.9), though specificity was significantly lower ( P = 0.026). Sensitivity was higher for high-grade tumors compared to low-grade tumors (94% vs. 60%, P = 0.002).

Conclusion

Validation of the GHSR/MAL methylation marker panel on at home collected urine samples confirms its robust performance for bladder cancer detection in a hematuria population, and underscores the diagnostic potential for future clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsDNA MethylationBiomarkers, TumorHumansMaleFemaleAgedMiddle AgedReceptors, GhrelinSensitivity and SpecificityMutL Protein Homolog 1Aged, 80 and over

Stichwörter der Autor:innen

(MeSH): bladder CancerBiomarkerDNA methylationDetectionLiquid biopsyUrineValidation

Substanzen

Biomarkers, TumorReceptors, GhrelinMutL Protein Homolog 1

Autor:innen und Institutionen

  • Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Urology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Department of Urology, OLVG, Amsterdam, The Netherlands.
  • Department of Epidemiology and Data Science, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. r.steenbergen@amsterdamumc.nl.

Zitieren

APA

Beijert, I. J., van den Burgt, Y., Hentschel, A. E., Bosschieter, J., Kauer, P. C., Lissenberg-Witte, B. I., van Moorselaar, R. J. A., Nieuwenhuijzen, J. A., & Steenbergen, R. D. M. (2024). Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-05287-5

Vancouver

Beijert IJ, van den Burgt Y, Hentschel AE, Bosschieter J, Kauer PC, Lissenberg-Witte BI, et al. Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study. World Journal of Urology. 2024;42(1). doi:10.1007/s00345-024-05287-5

BibTeX
@article{Beijert2024,
  author = {Beijert, I J and van den Burgt, Y and Hentschel, A E and Bosschieter, J and Kauer, P C and Lissenberg-Witte, B I and van Moorselaar, R J A and Nieuwenhuijzen, J A and Steenbergen, R D M},
  title = {Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study},
  journal = {World Journal of Urology},
  year = {2024},
  volume = {42},
  number = {1},
  doi = {10.1007/s00345-024-05287-5}
}
Kostenlos starten →